Concepedia

Martin Rose

MR

Statistics

Publications

5

Citations

134

H-Index

5

Active since

1986

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

National Institutes of Health

Martin Rose is an author at United States Food and Drug Administration specializing in medicine, cardiovascular disease, and public health.

Top concepts

MedicinePublic HealthCardiovascular DiseaseNursingBiomarkersCardiologyEpidemiologyHypertensionBiostatisticsHealth Policy

Publications per year

1986–2018

5

Publications

5

FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock

Fortunato Fred Senatore, Gowraganahalli Jagadeesh, Martin Rose et al. · American Journal of Cardiovascular Drugs · 2018 · 39 citations · Full text

Hypertension, Cardiogenic Shock, Angiotensin Ii +10

Personalized Cardiovascular Medicine Today

Alison Blaus, Rajanikanth Madabushi, Michael Pacanowski et al. · Circulation · 2015 · 35 citations · Full text

Prognostic Biomarkers, Heart Failure, Cardiovascular Disease +14

Challenges and Priorities for Research

Brian W. McCrindle, Jennifer S. Li, Cedric Manlhiot et al. · Circulation · 2014 · 33 citations

Research-practice Partnership, Science And Technology Studies, Research Ethics +2

Risk of acute myocardial infarction, stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers — a cohort study using the Clinical Practice Research Datalink

Esther H. Zhou, Kate Gelperin, Mark Levenson et al. · Pharmacoepidemiology and Drug Safety · 2013 · 15 citations

Transfer of Information and Its Impact on Medical Practice: The U.S. Experience

Itzhak Jacoby, Martin Rose · International Journal of Technology Assessment in Health Care · 1986 · 12 citations

Practice Management, Consensus Development Program, Clinical System +19

1–5 of 5